4//SEC Filing
KARBE FRANK 4
Accession 0001610618-25-000012
CIK 0001610618other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 6:31 PM ET
Size
7.5 KB
Accession
0001610618-25-000012
Insider Transaction Report
Form 4
KARBE FRANK
Chief Financial Officer
Transactions
- Award
Common Stock
2025-02-24+57,500→ 57,500 total - Award
Employee Stock Option (right to buy)
2025-02-24+115,000→ 115,000 totalExercise: $20.50Exp: 2035-02-23→ Common Stock (115,000 underlying)
Footnotes (2)
- [F1]Represents time-based Restricted Stock Units (RSUs) granted on February 24, 2025. All RSUs vest in four equal annual installments, with 1/4 vesting on each of March 10, 2026, 2027, 2028, and 2029, subject to continuous service through each such vesting date.
- [F2]25% of the shares subject to the option shall vest on the 1st anniversary of the vesting commencement date of February 24, 2025, and the balance of the shares shall vest in a series of 36 equal monthly installments measured from the 1st anniversary of the vesting commencement date, such that the option will be fully vested on February 24, 2029, subject to continuous service through each such vesting date.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 6:31 PM ET
- Size
- 7.5 KB